Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "Membranous nephropathy"
Show Display Options
RSS Create an RSS feed from your search for:
"Membranous nephropathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting MEmbranous Nephropathy Trial Of Rituximab
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Rituximab;   Drug: Cyclosporine
2 Withdrawn Aliskiren in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Aliskiren
3 Recruiting Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
Condition: MEMBRANOUS NEPHROPATHY
Interventions: Drug: TACROLIMUS;   Drug: RITUXIMAB;   Drug: METHYLPREDNISOLONE;   Drug: CYCLOPHOSPHAMIDE
4 Active, not recruiting Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin);   Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
5 Completed Rituximab in Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Drug: Rituximab
6 Active, not recruiting Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Losartan Tablets & QingReMoShen Granule;   Drug: Losartan Tablets & Placebo Granule
7 Completed Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Drug: Rituximab
8 Recruiting Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
Condition: Membranous Nephropathy
Intervention: Procedure: Blood and urine analysis
9 Completed Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: tetracosactide hexacetaat
10 Completed Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: ACTH
11 Unknown  Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine;   Drug: The immunosuppressive agents
12 Completed Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: Cyclophosphamide and steroids
13 Completed Mycophenolate Mofetil in Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: mycophenolate mofetil orally 1000 mg twice a day (BID);   Drug: prednisone 0,5 mg/kg orally on alternate days;   Drug: intravenous (i.v.) methylprednisolone 1000 mg, total 9
14 Completed To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
Condition: Membranous Nephropathy
Intervention: Drug: TW
15 Recruiting Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Mycophenolate mofetil, low dose steroid;   Drug: Cyclosporin, low dose steroid
16 Completed Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Tacrolimus
17 Completed Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: Tripterygium wilfordii;   Drug: FK506
18 Active, not recruiting Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Conditions: Proteinuria;   Idiopathic Membranous Nephropathy
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo
19 Withdrawn Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Condition: Glomerulonephritis, Membranous
Interventions: Drug: Belimumab 10 mg;   Drug: Placebo
20 Not yet recruiting Study on the Therapeutic Effect of TCM Treatment for MDR MN
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Jianpixiaozhong particles and Wuse Dietotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.